Bio-Techne Corporation
TECH
Ранг среди акций
#1874
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Цена акции
$72.55
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$11.38B
Изменение (1 день)
0.03%
Изменение (1 год)
17.27%
Страна
US
Торговля Bio-Techne Corporation (TECH)
Категория
Healthcare
Операционная маржа для Bio-Techne Corporation (TECH)
Операционная маржа на October 2026 TTM: 20.73%
Согласно последним финансовым отчетам и цене акций Bio-Techne Corporation, текущая операционная маржа (TTM) составляет 20.73%. В конце 2024 она составила 17.83%.
История операционной маржи Bio-Techne Corporation с 2000 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 20.73% | 147.37% |
| 2025 | 8.38% | -53.00% |
| 2024 | 17.83% | -32.21% |
| 2023 | 26.30% | -1.98% |
| 2022 | 26.83% | 67.06% |
| 2021 | 16.06% | 58.85% |
| 2020 | 10.11% | -42.52% |
| 2019 | 17.59% | -16.95% |
| 2018 | 21.18% | -2.08% |
| 2017 | 21.63% | -28.33% |
| 2016 | 30.18% | -7.17% |
| 2015 | 32.51% | -27.19% |
| 2014 | 44.65% | -12.49% |
| 2013 | 51.02% | -3.44% |
| 2012 | 52.84% | -6.03% |
| 2011 | 56.23% | -3.22% |
| 2010 | 58.10% | 1.72% |
| 2009 | 57.12% | 1.91% |
| 2008 | 56.05% | 0.90% |
| 2007 | 55.55% | 3.73% |
| 2006 | 53.55% | -2.14% |
| 2005 | 54.72% | 7.25% |
| 2004 | 51.02% | 9.25% |
| 2003 | 46.70% | 15.74% |
| 2002 | 40.35% | 1.61% |
| 2001 | 39.71% | 4.80% |
| 2000 | 37.89% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 38.59% | -98.14% |
US
|
|
| -149.01% | -107.19% |
US
|
|
| 25.57% | -98.77% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -98.61% |
NL
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.